1. Development of Resistance to Ofloxacin

   • G. C. Crumplin
   • M. Odell

   Section 1: Antibacterial Properties of Ofloxacin 27 November 2012 Pages: 1 - 8

2. Bactericidal Activity of Ofloxacin versus Roxithromycin in the Treatment of Streptococcus pneumoniae

   • P. M. Shah
   • V. Schäfer
   • W. Stille

   Section 1: Antibacterial Properties of Ofloxacin 27 November 2012 Pages: 9 - 13

3. Interpretive Criteria for the Agar Diffusion Susceptibility Test with Ofloxacin

   • Heinz Grimm

   Section 1: Antibacterial Properties of Ofloxacin 27 November 2012 Pages: 14 - 19

4. General Discussion: Section 1

   Section 1: Antibacterial Properties of Ofloxacin 27 November 2012 Pages: 20 - 20

5. Comparative Pharmacokinetics of New Quinolones

   • H. Lode
   • G. Höffken
   • P. Koeppe

   Section 2: Pharmacokinetic Profile of Oxfloxacin 27 November 2012 Pages: 21 - 25

6. Penetration of Ofloxacin from Blood to Sputum

   • B. I. Davies
   • F. P. V. Maesen
   • C. Baur

   Section 2: Pharmacokinetic Profile of Oxfloxacin 27 November 2012 Pages: 26 - 32

7. Penetration of Ofloxacin into Bronchial Secretions

   • J. Symonds
   • M. Bone
   • A. Javaid

   Section 2: Pharmacokinetic Profile of Oxfloxacin 27 November 2012 Pages: 33 - 36

8. Diffusion of Ofloxacin into Human Lung Tissue

   • L. Couraud
   • J. B. Fourtillan
   • M. Vincent du Laurier

   Section 2: Pharmacokinetic Profile of Oxfloxacin 27 November 2012 Pages: 37 - 38

9. Biliary Tract Excretion of Ofloxacin in Man

   • Antoine Kazmierczak
   • André Pechinot
   • Jean-Pierre Favre

   Section 2: Pharmacokinetic Profile of Oxfloxacin 27 November 2012 Pages: 39 - 43

10. In Vitro Activity and Concentrations in Serum, Urine, Prostatic Secretion and Adenoma Tissue of Ofloxacin in Urological Patients

    • K. G. Naber
    • D. Adam
    • F. Kees

    Section 2: Pharmacokinetic Profile of Oxfloxacin 27 November 2012 Pages: 44 - 50

11. Pharmacokinetics of Ofloxacin in Healthy Subjects and Patients with Impaired Renal Function

    • D. Höffler
    • P. Koeppe

    Section 2: Pharmacokinetic Profile of Oxfloxacin 27 November 2012 Pages: 51 - 55

12. A Preliminary Report on the Pharmacokinetics of Ofloxacin, Desmethyl Ofloxacin and Ofloxacin N-Oxide in Patients with Chronic Renal Failure

    • L. O. White
    • A. P. MacGowan
    • I. G. Mackay

    Section 2: Pharmacokinetic Profile of Oxfloxacin 27 November 2012 Pages: 56 - 61

13. Pharmacokinetics of Ofloxacin in Patients on Haemodialysis Treatment

    • A. Dörfler III
    • W. Schulz
    • M. Zichner

    Section 2: Pharmacokinetic Profile of Oxfloxacin 27 November 2012 Pages: 62 - 70

14. An Open Randomised Comparison of Ofloxacin and Doxycycline in Lower Respiratory Tract Infections

    • Helmut Harazim
    • Johann Wimmer
    • Hans P. Mittermayer

    Section 3: Ofloxacin in Respiratory Tract Infections 27 November 2012 Pages: 71 - 73

15. The Use of Quinolones in Respiratory Tract Infections

    • F. P. V. Maesen
    • B. I. Davies
    • C. Baur

    Section 3: Ofloxacin in Respiratory Tract Infections 27 November 2012 Pages: 74 - 79

16. Clinical Efficacy of Ofloxacin in Lower Respiratory Tract Infections

    • C. Grassi
    • G. Gialdroni Grassi
    • P. Mangiarotti

    Section 3: Ofloxacin in Respiratory Tract Infections 27 November 2012 Pages: 80 - 82

17. Ofloxacin in Respiratory Tract Infection

    • Atsushi Saito
    • Masataka Katsu
    • Rinzo Soejima

    Section 3: Ofloxacin in Respiratory Tract Infections 27 November 2012 Pages: 83 - 89

18. General Discussion: Section 3

    Section 3: Ofloxacin in Respiratory Tract Infections 27 November 2012 Pages: 90 - 90

19. Open Randomised Comparison of Ofloxacin and Norfloxacin in the Treatment of Complicated Urinary Tract Infections

    • Erwin W. Rugendorff

    Section 4: Ofloxacin in Respiratory Tract Infections 27 November 2012 Pages: 91 - 94

20. Clinical Experience with Ofloxacin in Upper and Lower Urinary Tract Infections

    • G. Ludwig
    • H. Pauthner

    Section 4: Ofloxacin in Respiratory Tract Infections 27 November 2012 Pages: 95 - 99

21. Ofloxacin versus Trimethoprim-Sulphamethoxazole in Acute Cystitis

    • J. M. Block
    • R. A. Walstad
    • L. -E. Peterson

    Section 4: Ofloxacin in Respiratory Tract Infections 27 November 2012 Pages: 100 - 106

22. Single Doses of Ofloxacin in Uncomplicated Gonorrhoea

    • J. Aznar
    • R. Prados
    • Evelio J. Perea

    Section 4: Ofloxacin in Respiratory Tract Infections 27 November 2012 Pages: 107 - 110

23. Acute Nongonococcal Epididymitis

    • W. Weidner
    • H. G. Schiefer
    • Ch. Garbe

    Section 4: Ofloxacin in Respiratory Tract Infections 27 November 2012 Pages: 111 - 117

24. Chairman’s Review

    • K. Moehring

    Section 3: Ofloxacin in Respiratory Tract Infections 27 November 2012 Pages: 118 - 118

25. Efficacy and Tolerance of Oral Ofloxacin in Treating Various Infections

    • Helen Giamarellou
    • John Tsagarakis

    Section 5: Ofloxacin in Other Infections 27 November 2012 Pages: 119 - 123

26. Ofloxacin Treatment in the Management of Chronic Osteitis

    • R. Ketterl
    • T. Beckurts
    • B. Claudi

    Section 5: Ofloxacin in Other Infections 27 November 2012 Pages: 124 - 130

27. Antimicrobial Prophylaxis in Immunocompromised Patients

    • J. H. Hartlapp

    Section 5: Ofloxacin in Other Infections 27 November 2012 Pages: 131 - 133

28. The Possible Role of Quinolones in Yersiniosis

    • J. A. A. Hoogkamp-Korstanje

    Section 5: Ofloxacin in Other Infections 27 November 2012 Pages: 134 - 138

29. Chemotherapy of Otitis Media with Ofloxacin

    • T. Lenarz

    Section 5: Ofloxacin in Other Infections 27 November 2012 Pages: 139 - 143

30. Side Effects of Ofloxacin in Clinical Trials and in Postmarketing Surveillance

    • Günther Jüngst
    • Rüdiger Mohr

    Section 6: The Safety Profile of Ofloxacin and Drug Interaction Studies 27 November 2012 Pages: 144 - 149

31. Overview of Toxicological Studies

    • D. G. Mayer

    Section 6: The Safety Profile of Ofloxacin and Drug Interaction Studies 27 November 2012 Pages: 150 - 153

32. Influence of Ofloxacin on the Faecal Flora

    • Tore Midtvedt

    Section 6: The Safety Profile of Ofloxacin and Drug Interaction Studies 27 November 2012 Pages: 154 - 158

33. Steady-State Kinetics of the Quinolone Derivatives Ofloxacin, Enoxadn, Ciprofloxacin and Pefloxacin during Maintenance Treatment with Theophylline

    • W. J. A. Wijnands
    • T. B. Vree
    • C. L. A. van Herwaarden

    Section 6: The Safety Profile of Ofloxacin and Drug Interaction Studies 27 November 2012 Pages: 159 - 169

34. Interaction Between Quinolones and Caffeine

    • A. H. Staib
    • W. Stille
    • C. Beer

    Section 6: The Safety Profile of Ofloxacin and Drug Interaction Studies 27 November 2012 Pages: 170 - 174

35. Chairman’s Review

    • R. Wise

    Section 6: The Safety Profile of Ofloxacin and Drug Interaction Studies 27 November 2012 Pages: 175 - 175

36. Present Day Susceptibility of Urinary Pathogens to Antimicrobials

    • M. S. Sabbour
    • L. M. Osman
    • W. F. El-Baz

    Section 7: Short Communication 27 November 2012 Pages: 176 - 177

37. Ofloxacin in Cystic Fibrosis

    • H. Meyer

    Section 7: Short Communication 27 November 2012 Pages: 177 - 179

38. Ofloxacin in Lower Respiratory Tract Infections

    • Pentti Hänninen

    Section 7: Short Communication 27 November 2012 Pages: 179 - 180

39. Activity of Ofloxacin against Chlamydia trachomatis

    • Birger R. Møller
    • Roger Evans
    • Ellis From

    Section 7: Short Communication 27 November 2012 Pages: 181 - 182

40. Application of Ofloxacin in Gynaecology

    • Eiko E. Petersen
    • Teresa Sanabria de Isele
    • Norbert Weiss

    Section 7: Short Communication 27 November 2012 Pages: 183 - 186

41. Epididymitis

    • H. W. Asbach
    • M. D. Melekos

    Section 7: Short Communication 27 November 2012 Pages: 186 - 187